These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25770462)

  • 1. The mechanism and significance of synergistic induction of the expression of plasminogen activator inhibitor-1 by glucocorticoid and transforming growth factor beta in human ovarian cancer cells.
    Pan XY; Wang Y; Su J; Huang GX; Cao DM; Qu S; Lu J
    Mol Cell Endocrinol; 2015 May; 407():37-45. PubMed ID: 25770462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of steroid receptor coactivators in glucocorticoid and transforming growth factor beta regulation of plasminogen activator inhibitor gene expression.
    Li G; Heaton JH; Gelehrter TD
    Mol Endocrinol; 2006 May; 20(5):1025-34. PubMed ID: 16423881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of plasminogen activator inhibitor (PAI)-1 expression in a human trophoblast cell line by glucocorticoid (GC) and transforming growth factor (TGF)-beta.
    Ma Y; Ryu JS; Dulay A; Segal M; Guller S
    Placenta; 2002 Nov; 23(10):727-34. PubMed ID: 12398812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
    Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
    Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC-mediated control of ERK- and PI3K-dependent TGF-β-induced extracellular matrix-regulating genes.
    Barter MJ; Pybus L; Litherland GJ; Rowan AD; Clark IM; Edwards DR; Cawston TE; Young DA
    Matrix Biol; 2010 Sep; 29(7):602-12. PubMed ID: 20470885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts.
    He S; Liu X; Yang Y; Huang W; Xu S; Yang S; Zhang X; Roberts MS
    Br J Dermatol; 2010 Mar; 162(3):538-46. PubMed ID: 19772524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERK contributes to the effects of Smad signaling on oxidized LDL-induced PAI-1 expression in human mesangial cells.
    Hong HK; Song CY; Kim BC; Lee HS
    Transl Res; 2006 Oct; 148(4):171-9. PubMed ID: 17002919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione suppresses TGF-beta-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter.
    Vayalil PK; Iles KE; Choi J; Yi AK; Postlethwait EM; Liu RM
    Am J Physiol Lung Cell Mol Physiol; 2007 Nov; 293(5):L1281-92. PubMed ID: 17890327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation and transforming growth factor-beta cooperate in transcriptional activation of the profibrotic plasminogen activator inhibitor-1 gene.
    Hageman J; Eggen BJ; Rozema T; Damman K; Kampinga HH; Coppes RP
    Clin Cancer Res; 2005 Aug; 11(16):5956-64. PubMed ID: 16115939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth state-dependent regulation of plasminogen activator inhibitor type-1 gene expression during epithelial cell stimulation by serum and transforming growth factor-beta1.
    Boehm JR; Kutz SM; Sage EH; Staiano-Coico L; Higgins PJ
    J Cell Physiol; 1999 Oct; 181(1):96-106. PubMed ID: 10457357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells.
    Chen YX; Wang Y; Fu CC; Diao F; Song LN; Li ZB; Yang R; Lu J
    Endocr Relat Cancer; 2010 Mar; 17(1):39-50. PubMed ID: 19776289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid receptor inhibits transforming growth factor-beta signaling by directly targeting the transcriptional activation function of Smad3.
    Song CZ; Tian X; Gelehrter TD
    Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11776-81. PubMed ID: 10518526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells.
    Song CY; Kim BC; Lee HS
    Transl Res; 2008 Jan; 151(1):27-35. PubMed ID: 18061125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperation of H2O2-mediated ERK activation with Smad pathway in TGF-beta1 induction of p21WAF1/Cip1.
    Kim YK; Bae GU; Kang JK; Park JW; Lee EK; Lee HY; Choi WS; Lee HW; Han JW
    Cell Signal; 2006 Feb; 18(2):236-43. PubMed ID: 15979845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF beta-induced Smad signaling remains intact in primary human ovarian cancer cells.
    Dunfield LD; Dwyer EJ; Nachtigal MW
    Endocrinology; 2002 Apr; 143(4):1174-81. PubMed ID: 11897669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
    Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
    J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite and independent actions of cyclic AMP and transforming growth factor beta in the regulation of type 1 plasminogen activator inhibitor expression.
    Thalacker FW; Nilsen-Hamilton M
    Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):855-62. PubMed ID: 1332686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid enhances hypoxia- and/or transforming growth factor-β-induced plasminogen activator inhibitor-1 production in human proximal renal tubular cells.
    Kimura H; Li X; Torii K; Okada T; Kamiyama K; Mikami D; Kasuno K; Takahashi N; Yoshida H
    Clin Exp Nephrol; 2011 Feb; 15(1):34-40. PubMed ID: 21042829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of glucocorticoid receptor transactivity and cell growth inhibition by transforming growth factor-beta through AP-1-mediated transcriptional repression.
    Periyasamy S; Sánchez ER
    Int J Biochem Cell Biol; 2002 Dec; 34(12):1571-85. PubMed ID: 12379279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.